Antiepileptic drugs and non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
Waldmann, M
Sturm, W
Naser, A
Unterberger, I
Trinka, E
Bauer, G
Lechleitner, M
Luef, G
机构：
[1] Med Univ Innsbruck, Univ Klin Neurol, Innsbruck, Austria
[2] Med Univ Innsbruck, Univ Klin Innere Med, Innsbruck, Austria
来源：
EPILEPSIA | 2004年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：161 / 162
页数：2
相关论文
共 50 条
  • [21] Prevalence of non-alcoholic fatty liver disease (NAFLD) in Singapore
    Tan, H. H.
    Chang, J. P. E.
    Chin, C.
    Tan, C. K.
    Lui, H. F.
    Chow, W. C.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A444 - A445
  • [22] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND RESPIRATORY FUNCTIONS
    Ozkarafakili, Mufide Arzu
    Ga, Salih Bo
    Ozguven, M. Banu Yilmaz
    [J]. RESPIROLOGY, 2018, 23 : 198 - 198
  • [23] Non-alcoholic Fatty Liver Disease Diagnosis and Therapy of NAFLD
    Canbay, Ali
    Lammert, Frank
    Geier, Andreas
    [J]. INTERNIST, 2021, 62 (05): : 485 - 485
  • [24] Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment
    Luef, G.
    Rauchenzauner, M.
    Waldmann, M.
    Sturm, W.
    Sandhofer, A.
    Seppi, K.
    Trinka, E.
    Unterberger, I.
    Ebenbichler, C. F.
    Joannidis, M.
    Walser, G.
    Bauer, G.
    Hoppichler, F.
    Lechleitner, M.
    [J]. EPILEPSY RESEARCH, 2009, 86 (01) : 42 - 47
  • [25] Other disease associations with non-alcoholic fatty liver disease (NAFLD)
    Allard, JP
    [J]. BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2002, 16 (05) : 783 - 795
  • [26] Non-alcoholic steatohepatitis (NASH)/non-alcoholic fatty liver disease (NAFLD) - A growing epidemic
    South, K
    [J]. GASTROENTEROLOGY NURSING, 2006, 29 (02) : 169 - 169
  • [27] Fatty Liver Index (FLI) in Predicting Non-alcoholic Fatty Liver Disease (NAFLD)
    Dehnavi, Zahra
    Razmpour, Farkhonde
    Naseri, Mahmoud Belghaisi
    Nematy, Mohsen
    Alamdaran, Seyed Ali
    Vatanparast, Hassan Ali
    Nezhad, Mohsen Azimi
    Abbasi, Bita
    Ganji, Azita
    [J]. HEPATITIS MONTHLY, 2018, 18 (02)
  • [28] Emerging drugs for non-alcoholic fatty liver disease
    Federico, Alessandro
    Niosi, Marco
    Blanco, Camillo Del Vecchio
    Loguercio, Carmela
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2008, 13 (01) : 145 - 158
  • [29] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. LABORATORY INVESTIGATION, 2003, 83 (01) : 283A - 283A
  • [30] Leptin as a marker of liver fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Petrovic, LM
    Alba, LM
    Lindor, KD
    Talwakar, JA
    Angulo, P
    [J]. MODERN PATHOLOGY, 2003, 16 (01) : 283A - 283A
12345